Roy Jefferis is in the Division of Immunity and Infection, The Medical School, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, UK. r.jefferis@bham.ac.uk
The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
